CSR Synopses following approval of a new medicine or a new indication for an approved medicine in the US or EU. We are making CSR synopses available to supplement the public information available to patients and healthcare providers about the results of our clinical trials and the evidence used to approve a new medicine or a new indication.
Divalproex Sodium: Depakote, Epival, Valcote
| Study Name | |||
|---|---|---|---|
| M02-547 | Schizophrenia | CSR.ORG | A Randomized, Double-Blind Study of the Safety and Efficacy of Depakote ER plus an Atypical Antipsychotic vs. an Atypical Antips… |
| M03-647 | Bipolar Disorder | CSR.ORG | An Open-Label Study to Evaluate the Safety of Depakote® ER in the Treatment of Mania Associated with Bipolar I Disorder in Child… |
| M03-648 | Migraine | CSR.ORG | Divalproex Sodium Extended-Release Tablets for Migraine Prophylaxis in Adolescents: An Open-Label, Long-Term Safety Study Abb… |
| M02-461 | Epilepsy (Seizures) | CSR.ORG | A 14-Day, Randomized, Open-Label, Cross-Over, Single Center Outpatient Study of Depakote Delayed-Release or Depakote Sprinkle vs… |
| M02-555 | Bipolar Disorder | CSR.ORG | An Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated… |
| M02-554 | Migraine | CSR.ORG | The Safety of Divalproex Sodium Extended Release Tablets in Migraine Prophylaxis: An Open-Label Extension Study in Adolescents… |
| M01-342 | Bipolar Disorder | CSR.ORG | A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Depakote ER for the Treatment of Mania Associat... |
| M04-714 | Partial Seizures | CSR.ORG | An Open-Label Multicenter Study of the Long-Term Safety of Depakote® Sprinkle Capsules in the Treatment of Partial Seizures in C… |
| M02-488 | Migraine | Phase 3 | The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Double-Blind, Placebo-Controlle.. |
| M02-540 | Bipolar Disorder | CSR.ORG | A 21-Day, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of Depakote ER in the Treatment… |
| M02-551 | Depression-Bipolar | Phase 4 | A Randomized, Double-Blind Study of Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase Of Bipolar Illness |